{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T02:38:04Z","timestamp":1788748684364,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim of this study was to examine the characteristics of infant mortality associated with critical congenital heart disease (CCHD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In a cross-sectional study, data for the study were obtained through Death Notification System, Birth Notification System and Turkish Statistical Institute birth statistics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of all infant deaths, 9.8% (4083) were associated with CCHD, and the infant mortality rate specific to CCHD was 8.8 per 10,000 live births. CCHD-related infant deaths accounted for 8.0% of all neonatal deaths, while the CCHD specific neonatal death rate was 4.6 per 10,000 live births. Of the deaths 21.7% occurred in the early neonatal, 30.3% in the late neonatal and 48.0% in the post neonatal period. Group 1 diseases accounted for 59.1% (<jats:italic>n<\/jats:italic>\u2009=\u20092415) of CCHD related infant deaths, 40.5% (<jats:italic>n<\/jats:italic>\u2009=\u20091652) were in Group 2 and 0.4% (<jats:italic>n<\/jats:italic>\u2009=\u200916) were in the unspecified group. Hypoplastic left heart syndrome was the most common CCHD among infant deaths (<jats:italic>n<\/jats:italic>\u2009=\u20091012; 24.8%). The highest CCHD related mortality rate was found in infants with preterm birth and low birth-weight while multiparity, maternal age\u2009\u2265\u200935 years, twin\/triplet pregnancy, male gender, maternal education in secondary school and below, and cesarean delivery were also associated with higher CCHD related infant mortality rate. There was at least one non-cardiac congenital anomaly\/genetic disorder in 26.1% of all cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>CCHD holds a significant role in neonatal and infant mortality in T\u00fcrkiye. To mitigate CCHD-related mortality rates, it is crucial to enhance prenatal diagnosis rates and promote widespread screening for neonatal CCHD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-024-17966-4","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T12:02:29Z","timestamp":1707739349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Investigation of infant deaths associated with critical congenital heart diseases; 2018\u20132021, T\u00fcrkiye"],"prefix":"10.1186","volume":"24","author":[{"given":"Nilg\u00fcn","family":"\u00c7aylan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9061-4281","authenticated-orcid":false,"given":"S\u0131ddika Song\u00fcl","family":"Yal\u00e7in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ba\u015fak","family":"Tezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oben","family":"\u00dcner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eirin","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"issue":"9715","key":"17966_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0140-6736(09)61922-X","volume":"375","author":"PW Tennant","year":"2010","unstructured":"Tennant PW, Pearce MS, Bythell M, Rankin J. 20-year survival of children born with congenital anomalies: a population-based study. Lancet. 2010;375(9715):649\u201356.","journal-title":"Lancet"},{"issue":"11","key":"17966_CR2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/bdra.20294","volume":"76","author":"MA Canfield","year":"2006","unstructured":"Canfield MA, Honein MA, Yuskiv N, Xing J, Mai CT, Collins JS, et al. National estimates and race\/ethnic-specific variation of selected birth defects in the United States, 1999\u20132001. Birth Defects Res Part A: Clin Mol Teratology. 2006;76(11):747\u201356.","journal-title":"Birth Defects Res Part A: Clin Mol Teratology"},{"issue":"3","key":"17966_CR3","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1542\/peds.107.3.e32","volume":"107","author":"LD Botto","year":"2001","unstructured":"Botto LD, Correa A, Erickson JD. Racial and temporal variations in the prevalence of heart defects. Pediatrics. 2001;107(3):e32\u2013e.","journal-title":"Pediatrics"},{"issue":"8","key":"17966_CR4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.110.958405","volume":"123","author":"H Dolk","year":"2011","unstructured":"Dolk H, Loane M, Garne E, Group aESoCAW. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation. 2011;123(8):841\u20139.","journal-title":"Circulation"},{"issue":"6","key":"17966_CR5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jpeds.2008.05.059","volume":"153","author":"MD Reller","year":"2008","unstructured":"Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998\u20132005. J Pediatr. 2008;153(6):807\u201313.","journal-title":"J Pediatr"},{"issue":"3","key":"17966_CR6","first-page":"237","volume":"48","author":"O Ba\u015fpinar","year":"2006","unstructured":"Ba\u015fpinar O, Karaaslan S, Oran B, Baysal T, Elmaci AM, Yorulmaz A. Prevalence and distribution of children with congenital heart diseases in the central anatolian region, Turkey. Turk J Pediatr. 2006;48(3):237\u201343.","journal-title":"Turk J Pediatr"},{"issue":"2","key":"17966_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1542\/peds.2009-1397","volume":"124","author":"WT Mahle","year":"2009","unstructured":"Mahle WT, Newburger JW, Matherne GP, Smith FC, Hoke TR, Koppel R, et al. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Pediatrics. 2009;124(2):823\u201336.","journal-title":"Pediatrics"},{"issue":"5","key":"17966_CR8","doi-asserted-by":"publisher","first-page":"e1502","DOI":"10.1542\/peds.2012-3435","volume":"131","author":"ME Oster","year":"2013","unstructured":"Oster ME, Lee KA, Honein MA, Riehle-Colarusso T, Shin M, Correa A. Temporal trends in survival among infants with critical congenital heart defects. Pediatrics. 2013;131(5):e1502\u2013e8.","journal-title":"Pediatrics"},{"key":"17966_CR9","doi-asserted-by":"publisher","unstructured":"Wu W, He J, Shao X. Incidence and mortality trend of congenital heart disease at the global, regional, and national level, 1990\u20132017. Medicine. 2020;99(23):e20593. https:\/\/doi.org\/10.1097\/MD.0000000000020593","DOI":"10.1097\/MD.0000000000020593"},{"issue":"11","key":"17966_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1136\/archdischild-2023-325471","volume":"108","author":"D Sasikumar","year":"2023","unstructured":"Sasikumar D, Prabhu MA, Kurup R, Francis E, Kumar S, Gangadharan ST, et al. Outcomes of neonatal critical congenital heart disease: results of a prospective registry-based study from South India. Arch Dis Child. 2023;108(11):889\u201394. https:\/\/doi.org\/10.1136\/archdischild-2023-325471","journal-title":"Arch Dis Child"},{"issue":"10","key":"17966_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/archdischild-2012-301662","volume":"97","author":"RL Knowles","year":"2012","unstructured":"Knowles RL, Bull C, Wren C, Dezateux C. Mortality with congenital heart defects in England and Wales, 1959\u20132009: exploring technological change through period and birth cohort analysis. Arch Dis Child. 2012;97(10):861\u20135.","journal-title":"Arch Dis Child"},{"issue":"1","key":"17966_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.21101\/cejph.a4097","volume":"24","author":"D Dilli","year":"2016","unstructured":"Dilli D, K\u00f6se MR, G\u00fcnd\u00fcz RC, \u00d6zba\u015f S, Tezel B, Okumu\u015f N. Recent declines in infant and neonatal mortality in Turkey from 2007 to 2012: impact of improvements in health policies. Cent Eur J Public Health. 2016;24(1):52\u20137.","journal-title":"Cent Eur J Public Health"},{"key":"17966_CR13","unstructured":"Tezel B, Kurulu\u015funun A\u015eSB. 100. Y\u0131l\u0131nda T\u00fcrkiye\u2019de Bebek \u00d6l\u00fcmleri Durum Raporu Ankara: TC Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131, Halk Sa\u011fl\u0131\u011f\u0131 Genel M\u00fcd\u00fcrl\u00fc\u011f\u00fc. 2021."},{"key":"17966_CR14","first-page":"666","volume":"111","author":"SAVA Lopes","year":"2018","unstructured":"Lopes SAVA, Guimar\u00e3es ICB, Costa SFO, Acosta AX, Sandes KA, Mendes CMC. Mortality for critical congenital heart diseases and associated risk factors in newborns. A cohort study. Arquivos brasileiros de cardiologia. 2018;111:666\u201373.","journal-title":"Arquivos brasileiros de cardiologia"},{"issue":"7","key":"17966_CR15","doi-asserted-by":"publisher","first-page":"e028139","DOI":"10.1136\/bmjopen-2018-028139","volume":"9","author":"MK Bakker","year":"2019","unstructured":"Bakker MK, Bergman JE, Krikov S, Amar E, Cocchi G, Cragan J, et al. Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort study. BMJ open. 2019;9(7):e028139.","journal-title":"BMJ open"},{"issue":"21","key":"17966_CR16","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1001\/jama.2017.17627","volume":"318","author":"R Abouk","year":"2017","unstructured":"Abouk R, Grosse SD, Ailes EC, Oster ME. Association of US state implementation of newborn screening policies for critical congenital heart disease with early infant cardiac deaths. JAMA. 2017;318(21):2111\u20138.","journal-title":"JAMA"},{"issue":"2","key":"17966_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/jcdd10020047","volume":"10","author":"N Derridj","year":"2023","unstructured":"Derridj N, Ghanchi A, Bonnet D, Adnot P, Rahshenas M, Salomon LJ, et al. Early Mortality in infants born with neonatally operated congenital heart defects and low or very-low birthweight: a systematic review and Meta-analysis. J Cardiovasc Dev Disease. 2023;10(2):47.","journal-title":"J Cardiovasc Dev Disease"},{"key":"17966_CR18","doi-asserted-by":"crossref","unstructured":"Pace ND, Oster ME, Forestieri NE, Enright D, Knight J, Meyer RE. Sociodemographic factors and survival of infants with congenital heart defects. Pediatrics. 2018;142(3):e20180302.","DOI":"10.1542\/peds.2018-0302"},{"key":"17966_CR19","unstructured":"Umut Z\u00fcbario\u011flu A, Y\u0131ld\u0131r\u0131m \u00d6, Balaban \u0130, Bakshaliyev S, Zeybek C. Kritik Konjenital Kalp Hastal\u0131kl\u0131 Yenido\u011fanlarda Perioperatif Mortaliteye Etki Eden Fakt\u00f6rlerin De\u011ferlendirilmesi. 2020."},{"issue":"2","key":"17966_CR20","first-page":"79","volume":"8","author":"N \u00dcST\u00dcN","year":"2014","unstructured":"\u00dcST\u00dcN N, ZENC\u0130RO\u011eLU A, BEKEN S, OKUMU\u015e N, \u00d6ZG\u00dcR S. Main risk factors for Mortality after Cardiovascular interventions in newborns with critical congenital Heart diseases. T\u00fcrkiye \u00c7ocuk Hastal\u0131klar\u0131 Dergisi. 2014;8(2):79\u201385.","journal-title":"T\u00fcrkiye \u00c7ocuk Hastal\u0131klar\u0131 Dergisi"},{"key":"17966_CR21","doi-asserted-by":"crossref","unstructured":"\u015eERO L, OKUR N, G\u00dcL \u00d6, DOYURGAN O, \u015e\u0130M\u015eEK M. BEZ\u0130RGANO\u011eLU H. B\u00fcy\u00fck Arter Transpozisyonu Olan Yenido\u011fanlarda Mortaliteyi Etkileyen Fakt\u00f6rlerin De\u011ferlendirilmesi. Forbes J Med. 2023;4(1):57.","DOI":"10.4274\/forbes.galenos.2022.07379"},{"key":"17966_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-023-03362-z","author":"D Dilli","year":"2024","unstructured":"Dilli D, Akduman H, Zenciro\u011flu A, \u00c7etinkaya M, Okur N, Turan \u00d6, et al. Neonatal outcomes of critical congenital heart defects: a Multicenter Epidemiological Study of Turkish neonatal society: neonatal outcomes of CCHD. Pediatr Cardiol. 2024;45(2):257\u201371. https:\/\/doi.org\/10.1007\/s00246-023-03362-z","journal-title":"Pediatr Cardiol"},{"key":"17966_CR23","unstructured":"Turkish Ministry of Health., Death Notification System [Internet]. [Date of access: 10th June 2023]. Available from: https:\/\/obs.saglik.gov.tr\/Account\/Login."},{"key":"17966_CR24","unstructured":"Turkish Ministry of Health., Birth Notification System [Internet]. Access date: 10th June 2023]. Available from: https:\/\/erapor.saglik.gov.tr\/portal\/."},{"key":"17966_CR25","unstructured":"Turkish Statistical Institute., Birth Statistics [Internet]. [Date of access: 10th June 2023]. Access address: https:\/\/data.tuik.gov.tr\/Bulten\/Index?p=Dogum-Istatistikleri-2021-45547."},{"key":"17966_CR26","unstructured":"World Health Organization. ICD-10 Version:2019. [Date of access: 10th June 2023]. Access address: https:\/\/icd.who.int\/browse10\/2019\/en#\/."},{"key":"17966_CR27","unstructured":"Dilli D, Varan B, Ta\u015fo\u011flu \u0130, O\u011fuz \u015eS, \u00c7aylan N, Tezel B. Neonatal Critical Congenital Heart Diseases Screening Guide. Ankara; 2021."},{"issue":"2","key":"17966_CR28","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1542\/peds.108.2.e35","volume":"108","author":"MS Kramer","year":"2001","unstructured":"Kramer MS, Platt RW, Wen SW, Joseph K, Allen A, Abrahamowicz M, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics. 2001;108(2):e35\u2013e.","journal-title":"Pediatrics"},{"key":"17966_CR29","unstructured":"Hacettepe University Institute of Population Studies. 2018 Turkey Demographic and Health Survey. Ankara, 2019."},{"issue":"8","key":"17966_CR30","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1136\/archdischild-2019-317581","volume":"105","author":"G Wik","year":"2020","unstructured":"Wik G, Jortveit J, Sitras V, D\u00f8hlen G, R\u00f8nnestad AE, Holmstr\u00f8m H. Severe congenital heart defects: incidence, causes and time trends of preoperative mortality in Norway. Arch Dis Child. 2020;105(8):738\u201343.","journal-title":"Arch Dis Child"},{"issue":"4","key":"17966_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1017\/S1047951119000052","volume":"29","author":"D Dilli","year":"2019","unstructured":"Dilli D, Do\u011fan V, \u00d6zyurt BM, \u00d6zyurt A, Hakan N, Bozabal\u0131 S, et al. Should we start a nationwide screening program for critical congenital heart disease in Turkey? A pilot study on four centres with different altitudes. Cardiol Young. 2019;29(4):475\u201380.","journal-title":"Cardiol Young"},{"issue":"20","key":"17966_CR32","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1080\/14767058.2018.1465551","volume":"32","author":"B \u00d6zer Bekmez","year":"2019","unstructured":"\u00d6zer Bekmez B, Alyama\u00e7 Dizdar E, Okur N, B\u00fcy\u00fcktiryaki M, Ura\u015f N, O\u011fuz SS. Does prenatal diagnosis of critical congenital heart diseases influence the prereferral mortality in a center without surgical intervention? J Maternal-Fetal Neonatal Med. 2019;32(20):3431\u20134.","journal-title":"J Maternal-Fetal Neonatal Med"},{"key":"17966_CR33","unstructured":"Turkish Ministry of Health. General Directorate of Public Health. Infant, child, adolescent follow-up protocols. Ankara; 2018."},{"key":"17966_CR34","doi-asserted-by":"publisher","first-page":"105457","DOI":"10.1016\/j.earlhumdev.2021.105457","volume":"162","author":"A Abbas","year":"2021","unstructured":"Abbas A, Ewer AK. New born pulse oximetry screening: a global perspective. Early Hum Dev. 2021;162:105457. https:\/\/doi.org\/10.1016\/j.earlhumdev.2021.105457.","journal-title":"Early Hum Dev"},{"key":"17966_CR35","first-page":"137","volume":"1","author":"A Gedikba\u015f\u0131","year":"2011","unstructured":"Gedikba\u015f\u0131 A, \u00d6ztarhan K, Y\u0131ld\u0131r\u0131m G, G\u00fcl A, Ceylan Y. Counseling and outcomes of antenatally diagnosed congenital heart anomalies in Turkey. Anadolu Kardiyol Derg. 2011;1:137\u201345.","journal-title":"Anadolu Kardiyol Derg"},{"issue":"1","key":"17966_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4274\/jtgga.galenos.2021.2021-8-10","volume":"23","author":"\u00d6K Can","year":"2022","unstructured":"Can \u00d6K, Kaleli B. Retrospective clinical evaluation of indications for termination of pregnancies due to fetal anomaly. J Turkish German Gynecol Association. 2022;23(1):28.","journal-title":"J Turkish German Gynecol Association"},{"issue":"1","key":"17966_CR37","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1186\/s12884-023-06193-1","volume":"23","author":"N \u00c7aylan","year":"2023","unstructured":"\u00c7aylan N, Yal\u00e7\u0131n SS, Tezel B, \u00dcner O, Aydin \u015e, Kara F. Evaluation of critical congenital heart disease from 2018 to 2020 in Turkey: a retrospective cohort study. BMC Pregnancy Childbirth. 2023;23(1):871. https:\/\/doi.org\/10.1186\/s12884-023-06193-1.","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-17966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-17966-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-17966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T12:02:50Z","timestamp":1707739370000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-17966-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["17966"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-17966-4","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,12]]},"assertion":[{"value":"19 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Hacettepe University Ethics Committee (Decision Number. 2020\/15\u2009\u2212\u200904), since the study has a retrospective study design. However, informed consent is obtained from all participants (mothers) having infant death with critical congenital heart disease during data entry into the Death Notification System, Birth Notification System and e-Nab\u0131z system, which includes the data of this study. Official approval was obtained from the MoH for the use and analysis of data (Official permission date and number: 22 July 2020; 67414668-234.02-E.485). The procedures used in this study adhere to the tenets of the Declaration of Helsinki, Good Clinical Practice guidelines, General Data Protection Regulation, and Data Protection Act. This study is based on anonymised data and no identifable or individual data are published. MoH delivered the cases with disease codes without personal data according to Hacettepe University Observational Clinical Studies Ethics Committee (Decision Number. 2020\/15\u2009\u2212\u200904).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"441"}}